Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement. (2026). SKIN The Journal of Cutaneous Medicine, 10(2), s726. https://doi.org/10.25251/mjfdzc48